William Blair & Company
EVH icon

William Blair & Company’s Evolent Health EVH Stock Holding History

William Blair & Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.9K Sell
35,039
-8,167
-19% -$25.9K ﹤0.01% 1632
2025
Q4 		$173K Sell
43,206
-395,725
-90% -$2.2M ﹤0.01% 1491
2025
Q3 		$3.71M Sell
438,931
-5,343
-1% -$51.8K 0.01% 594
2025
Q2 		$5M Sell
444,274
-180,366
-29% -$1.66M 0.01% 493
2025
Q1 		$5.92M Sell
624,640
-1,034,348
-62% -$10.4M 0.02% 439
2024
Q4 		$18.7M Sell
1,658,988
-497,127
-23% -$8.74M 0.05% 233
2024
Q3 		$61M Sell
2,156,115
-425,962
-16% -$11M 0.18% 116
2024
Q2 		$49.4M Sell
2,582,077
-687,142
-21% -$17.5M 0.15% 127
2024
Q1 		$107M Buy
3,269,219
+229,062
+8% +$7.31M 0.34% 72
2023
Q4 		$100M Buy
3,040,157
+189,150
+7% +$5.35M 0.34% 72
2023
Q3 		$77.6M Buy
2,851,007
+399,884
+16% +$11.1M 0.3% 79
2023
Q2 		$74.3M Buy
2,451,123
+102,540
+4% +$3.32M 0.27% 86
2023
Q1 		$76.2M Sell
2,348,583
-22,776
-1% -$720K 0.3% 80
2022
Q4 		$66.6M Buy
2,371,359
+18,779
+0.8% +$538K 0.29% 85
2022
Q3 		$84.5M Buy
2,352,580
+23,645
+1% +$833K 0.39% 66
2022
Q2 		$71.5M Sell
2,328,935
-37,931
-2% -$1.11M 0.32% 79
2022
Q1 		$76.5M Sell
2,366,866
-112,959
-5% -$2.96M 0.27% 90
2021
Q4 		$68.6M Sell
2,479,825
-78,360
-3% -$2.25M 0.22% 109
2021
Q3 		$79.3M Buy
2,558,185
+39,296
+2% +$943K 0.27% 87
2021
Q2 		$53.2M Buy
2,518,889
+127,207
+5% +$2.55M 0.18% 123
2021
Q1 		$48.3M Buy
2,391,682
+71,795
+3% +$1.37M 0.18% 128
2020
Q4 		$37.2M Buy
2,319,887
+15,480
+0.7% +$205K 0.14% 151
2020
Q3 		$28.6M Sell
2,304,407
-220,749
-9% -$2.6M 0.12% 162
2020
Q2 		$18M Buy
2,525,156
+1,621,400
+179% +$10.9M 0.09% 192
2020
Q1 		$4.91M Sell
903,756
-257,972
-22% -$2.3M 0.03% 332
2019
Q4 		$10.5M Buy
1,161,728
+152,305
+15% +$1.24M 0.05% 259
2019
Q3 		$7.26M Sell
1,009,423
-207,917
-17% -$1.49M 0.04% 305
2019
Q2 		$9.68M Sell
1,217,340
-159,278
-12% -$1.89M 0.06% 265
2019
Q1 		$17.3M Sell
1,376,618
-649,268
-32% -$10.3M 0.11% 182
2018
Q4 		$40.4M Sell
2,025,886
-115,385
-5% -$2.67M 0.29% 87
2018
Q3 		$60.8M Sell
2,141,271
-43,063
-2% -$1.03M 0.37% 70
2018
Q2 		$46M Sell
2,184,334
-293,970
-12% -$5.56M 0.31% 81
2018
Q1 		$35.3M Sell
2,478,304
-489,940
-17% -$7.01M 0.25% 97
2017
Q4 		$36.5M Sell
2,968,244
-170,516
-5% -$2.4M 0.25% 103
2017
Q3 		$55.9M Buy
3,138,760
+953,065
+44% +$19.6M 0.42% 62
2017
Q2 		$55.4M Buy
2,185,695
+523,674
+32% +$12.6M 0.42% 63
2017
Q1 		$32.7M Buy
1,662,021
+113,198
+7% +$2.17M 0.26% 100
2016
Q4 		$22.9M Buy
1,548,823
+904,661
+140% +$17.8M 0.21% 124
2016
Q3 		$15.9M Buy
644,162
+302,592
+89% +$7.07M 0.14% 175
2016
Q2 		$6.56M Buy
341,570
+229,748
+205% +$3.16M 0.06% 253
2016
Q1 		$1.18M Buy
+111,822
New +$1.16M 0.01% 579

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company's EVH Position: Q1 2026 in Review

William Blair & Company reduced its Evolent Health (EVH) stake by 19% in Q1 2026, selling an estimated $25.9K and leaving 35,039 shares worth $79.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

William Blair & Company first reported a position in EVH in Q1 2016 and has held it in 41 quarters since. The position peaked at $107M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • William Blair & Company held 35,039 shares of Evolent Health worth $79.9K as of Q1 2026.
  • William Blair & Company sold 8,167 Evolent Health shares in Q1 2026, an estimated $25.9K.
  • Evolent Health made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1632 holding.
  • William Blair & Company first reported a position in Evolent Health in Q1 2016 and has held it in 41 quarters since.
  • William Blair & Company's Evolent Health position peaked at $107M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.